| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |